Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Autologous Stem/Stromal Cells in Chronic Lung Disorders: Obstructive (COPD) and Restrictive (RLD)

NCT03909750 is registered in ClinicalTrials.gov with Healeon Medical Inc as lead sponsor.

NCT NCT03909750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03909750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Autologous Stem/Stromal Cells in Chronic Lung Disorders: Obstructive (COPD) and Restrictive (RLD)
Lead sponsor
Healeon Medical Inc
Phase
Phase 1
Overall status
Suspended
Start date
April 10, 2019
Completion date
September 30, 2026
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

copd, respiratory insufficiency